| 臺大學術典藏 |
2018-09-10T14:49:40Z |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Yu, Chong-Jen;Liao, Wei-Yu;Tsai, Chi-Ren;Tsai, Meen-Hsin;Yu, Sung-Liang;Su, Kang-Yi;Chen, Jeremy J. W.;Chen, Hsuan-Yu;Chang, Gee-Chen; Tseng, J.-S. and Yang, T.-Y. and Chen, K.-C. and Hsu, K.-H. and Yu, C.-J. and Liao, W.-Y. and Tsai, C.-R. and Tsai, M.-H. and Yu, S.-L. and Su, K.-Y. and Chen, J.J.W. and Chen, H.-Y. and Chang, G.-C.; 俞松良;蘇剛毅;廖唯昱;余忠仁; SUNG-LIANG YU; Tseng, Jeng-Sen; Tseng, Jeng-Sen; CHONG-JEN YU; Yang, Tsung-Ying; Yang, Tsung-Ying; Chen, Kun-Chieh; WEI-YU LIAO; Hsu, Kuo-Hsuan; KANG-YI SU; Yu, Chong-Jen; Yu, Chong-Jen; Liao, Wei-Yu; Liao, Wei-Yu; Tsai, Chi-Ren; Tsai, Meen-Hsin; Yu, Sung-Liang; Yu, Sung-Liang; Su, Kang-Yi; Su, Kang-Yi; Chen, Jeremy J. W.; Chen, Jeremy J. W.; Chen, Hsuan-Yu; Chen, Hsuan-Yu; Chang, Gee-Chen |
